Retinoic Acid-Functionalized Chitosan Polycationic Conjugates for Integrated Melanoma Therapy and Antibacterial Infection Control
ACS Biomaterials Science & Engineering · 2026
DOI: 10.1021/acsbiomaterials.6c00535 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Sijin Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Material Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China. Hauptthemen laut MEDLINE: Chitosan, Anti-Bacterial Agents, Tretinoin, Melanoma. Die Arbeit nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Nosokomiale Infektionen
Abstract (Originalsprache)
Malignant melanoma is an aggressive skin malignancy that is frequently complicated by bacterial infections during postoperative recovery. However, current therapeutic strategies rarely address infection-associated complications, highlighting the need for multifunctional biomaterials capable of simultaneously targeting tumor cells and pathogenic bacteria. Herein, retinoic acid (RA)-functionalized chitosan polycationic conjugates were well engineered to achieve integrated anticancer and antimicrobial activity. The incorporation of quaternary ammonium groups together with hydrophobic RA moieties enabled the rational regulation of charge density and hydrophilic–hydrophobic balance, resulting in improved aqueous solubility, bioactivity, and biocompatibility. The optimized conjugate inhibited melanoma cell proliferation (IC50 = 4 μg/mL) and exhibited broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria, with MIC values of 4–32 μg/mL. Mechanistic studies suggested that the polycationic conjugates act through multiple coordinated mechanisms, including membrane disruption, RAR/RXR-related signaling, ROS generation, and necrosis/apoptosis induction. In vivo experiments further demonstrated significant antitumor suppression (∼70% reduction in tumor volume) together with effective inhibition of S. aureus infection at wound sites (∼1.5-log reduction). These findings highlight RA-functionalized chitosan polycations as a promising multifunctional biomaterial system for melanoma therapy while addressing infection-associated complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Material Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China.
- Translational Medical Center for Stem Cell Therapy, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200331, China.
- Teaching Laboratory Center, School of Medicine, Tongji University, Shanghai 200331, China.
ORCID-Profile: Chuncai Zhou, Decheng Wan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, S., He, J., Shen, C., Qian, Y., Huang, S., Zhao, Y., Zhou, C., & Wan, D. (2026). Retinoic Acid-Functionalized Chitosan Polycationic Conjugates for Integrated Melanoma Therapy and Antibacterial Infection Control. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.6c00535
Vancouver
Chen S, He J, Shen C, Qian Y, Huang S, Zhao Y, et al. Retinoic Acid-Functionalized Chitosan Polycationic Conjugates for Integrated Melanoma Therapy and Antibacterial Infection Control. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.6c00535
BibTeX
@article{Chen2026,
author = {Chen, Sijin and He, Jing and Shen, Chenyun and Qian, Yusheng and Huang, Shuting and Zhao, Yan and Zhou, Chuncai and Wan, Decheng},
title = {Retinoic Acid-Functionalized Chitosan Polycationic Conjugates for Integrated Melanoma Therapy and Antibacterial Infection Control},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
doi = {10.1021/acsbiomaterials.6c00535}
}
EUVIMED